 |
Fibrinogen (human) |
|---|---|
| Trade Name | |
| Orphan Indication | For the control of bleeding and prophylactic treatment of patients deficient in fibrinogen |
| USA Market Approval | USA |
| USA Designation Date | 1995-08-23 00:00:00 |
| Sponsor | Alpha Therapeutic Corporation;5555 Valley Boulevard;Los Angeles, California, 90032 |
